Mocellin, S <br/><br/>
Targeting death receptors to fight cancer: from biological rational to clinical implementation.  [electronic resource] 

 -  Current medicinal chemistry  2010 
 - 2713-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1875-533X 
<br/><br/><label>Standard No.: </label>10.2174/092986710791859342  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--pharmacology<br/>Clinical Trials as Topic<br/>Drug Evaluation, Preclinical<br/>Drug Resistance, Neoplasm<br/>Fas Ligand Protein--pharmacology<br/>Humans<br/>Mice<br/>Mice, Transgenic<br/>Neoplasms--drug therapy<br/>Receptors, Death Domain--antagonists & inhibitors<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand--pharmacology<br/>Signal Transduction--drug effects<br/>TNF-Related Apoptosis-Inducing Ligand--pharmacology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors